SCHEMBL26313111

SCHEMBL26313111

c1ccc(-c2ccc(-c3nc(-c4ccc5c(c4)oc4ccc6ccccc6c45)nc4c3sc3ccccc34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.36
CYP1A1 P04798 2/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
LIMK1 P53667 3/20 0.36
PRKDC P78527 1/20 0.32
TNKS O95271 2/20 0.32
TNKS2 Q9H2K2 2/20 0.32
TDP1 Q9NUW8 3/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
CYP1B1 Q16678 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MAPK1 P28482 2/20 0.31
KMT2A Q03164 2/20 0.31
ESR2 Q92731 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24255937 0.91 LIMK1 (0.32) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL24548798 0.87 PRKDC (0.35) LIMK1PRKDCTNKSTNKS2TDP1
SCHEMBL22330199 0.86 LIMK1 (0.37) LIMK1PRKDCTNKSTNKS2L3MBTL1
SCHEMBL22329900 0.86 LIMK1 (0.37) LIMK1PRKDCTNKSTNKS2L3MBTL1
SCHEMBL22195576 0.86 LIMK1 (0.37) LIMK1PRKDCTNKSTNKS2L3MBTL1
SCHEMBL23740557 0.86 PRKDC (0.30) PRKDC
SCHEMBL25023007 0.86 LIMK1 (0.35) LIMK1PRKDCTNKSTNKS2ESR2
SCHEMBL23740391 0.86 LIMK1 (0.30) ABCG2CYP1A1PAX8CYP1A2FYN
SCHEMBL22329810 0.85 LIMK1 (0.38) LIMK1PRKDCTNKSTNKS2L3MBTL1
SCHEMBL23686366 0.85 LIMK1 (0.38) LIMK1PRKDCTNKSTNKS2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 ABCG2 1061/4885CYP1A1 63/4885PAX8 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.